Quick Overview: Experts consider the presence of germline and Felipe Batalini, MD, Beth Israel Deaconess Medical Center, Boston, MA, expresses how the clinical benefit of poly(ADP-ribose) ... Neelima Vidula, MD, Massachusetts General Hospital, Boston, MA, discusses a Phase
Detecting Somatic Brca1 2 Mutations - Detailed Overview & Context
Experts consider the presence of germline and Felipe Batalini, MD, Beth Israel Deaconess Medical Center, Boston, MA, expresses how the clinical benefit of poly(ADP-ribose) ... Neelima Vidula, MD, Massachusetts General Hospital, Boston, MA, discusses a Phase Panelists Robert L. Coleman, MD; Gottfried E. Konecny, MD; Bradley J. Monk, MD; Katie Moore, MD; and Matthew A. Powell, MD, ... Christine Desmedt, PhD, KU Leuven, Louvain, Belgium, presents findings from the monarchE trial (NCT03155997) on germline ... Basser Executive Director Susan Domchek, MD, discusses the differences between
Expert oncologists consider the use of olaparib and bevacizumab as maintenance therapy in patients with Genetic testing has advanced rapidly over the years. If you have had In this segment, moderator Maurie Markman, MD, and panelists Michael J. Birrer, MD, PhD, Warner K. Huh, MD, and Robert A. ... Oncology Institute of Southern Switzerland, discusses the management of Leigha Senter, MS, LGC, discusses the implications of Lori J. Pierce, MD, professor, Radiation Oncology, University of Michigan School of Medicine, discusses the difficulty of ...
In her talk, Jessica Baglieri introduces the audience to Presented At: Molecular Diagnostics Virtual Event 2019 Presented By: Anika Joecker, PhD - Associate Director Global Product ... Dr. Larissa Korde discusses the link between BRCA
